Trexquant Investment LP Buys Shares of 279,211 Sotera Health (NASDAQ:SHC)

Trexquant Investment LP purchased a new position in shares of Sotera Health (NASDAQ:SHC) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 279,211 shares of the company’s stock, valued at approximately $3,820,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after purchasing an additional 1,140 shares during the period. GAMMA Investing LLC raised its position in shares of Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after buying an additional 1,121 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company’s stock valued at $127,000 after acquiring an additional 2,627 shares in the last quarter. Envestnet Portfolio Solutions Inc. increased its stake in shares of Sotera Health by 17.3% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock valued at $217,000 after acquiring an additional 2,340 shares during the period. Finally, Oak Thistle LLC bought a new stake in Sotera Health during the fourth quarter worth approximately $222,000. Institutional investors own 91.03% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Barclays decreased their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, February 28th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Sotera Health has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.

Sotera Health Stock Performance

Shares of SHC opened at $10.34 on Monday. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The firm’s 50 day moving average is $12.61 and its 200-day moving average is $13.78. Sotera Health has a 12-month low of $10.05 and a 12-month high of $17.08. The stock has a market capitalization of $2.93 billion, a P/E ratio of 41.36 and a beta of 1.88.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.